Ezra Review

Ezra is one of the two major direct-to-consumer whole-body MRI companies. Prenuvo is the other. Ezra was the first US direct-to-consumer whole-body MRI provider. It uses AI-assisted image analysis alongside board-certified radiologist reads, and it sells a range of scan protocols rather than a single product — from a targeted 30-minute Flash at roughly $1,395 to a 90-minute Full Body Plus at roughly $2,395.

That tiering is the practical difference for most buyers. Whole-body MRI is a single-purchase product with no membership, no prescriptions and no ongoing clinical relationship. You pay once, you get a radiologist report, and what you do next is your own physician's problem. This review covers what each tier includes, what the scan can and cannot see, what the real year-one number looks like once follow-up is counted, and who should choose a different screening tool entirely.

Scorecard

What you get for the money

Ezra sells scan time and a radiologist read. Everything else is optional or absent. The three tiers differ almost entirely in how long you are in the scanner and how much anatomy is covered in that time.

• Ezra Flash (~30 min, ~$1,395). A targeted protocol over key organs. This is the entry point and the tier most first-time buyers choose. It is a genuine MRI read, not a screening questionnaire, but it images less anatomy than the longer protocols.
• Ezra Full Body (~60 min, ~$1,995). Comprehensive whole-body coverage. This is the tier that maps most closely to what Prenuvo sells as a standard full-body scan.
• Ezra Full Body Plus (~90 min, ~$2,395). The extended protocol, with additional sequences layered onto the full-body coverage.
• AI-assisted image analysis. Bundled at every tier. Machine-learning models pre-screen the images and flag regions for the radiologist to examine, which shortens turnaround.
• Board-certified radiologist review. Bundled. A human radiologist signs the report. The AI does not issue findings on its own.
• Written report with follow-up recommendations. Bundled. You receive the findings and the suggested next step for each one.
• Physician consult about the results. Included on some plans and an add-on on others, depending on market and tier. Confirm before you book if you want a clinician to walk you through the report.
• Not included: any treatment, prescription, or ongoing care. Ezra is an imaging company. There is no membership, no lab panel, and no clinician managing you after the report lands.

What it costs

The list price is straightforward and the tiers are published. The line most buyers miss is the last one: if the scan finds something, the confirmatory imaging, specialist visit or biopsy is billed by whoever performs it, not by Ezra. Whether insurance covers that depends on how your physician codes the referral, and a workup triggered by an elective screening scan is not guaranteed coverage.

Nothing here is insurance-covered on the front end. Health savings account and flexible spending account eligibility varies by plan administrator and is worth checking before you pay out of pocket, because the scan is elective screening rather than diagnostic imaging.

Signing up and the first visit

Booking is direct. You choose a tier and a clinic location online, complete a medical-history and MRI-safety questionnaire, and select an appointment. The safety questionnaire is the real gate — it screens for implanted devices, metal fragments, prior surgeries and claustrophobia, and it can disqualify you before you ever reach the scanner.

On the day, there is no needle, no contrast dye on the standard protocols, and no radiation. You change into scrubs, remove all metal, and lie still inside a closed MRI bore for the length of your protocol — roughly 30, 60 or 90 minutes depending on tier. The scanner is loud; ear protection is provided. Staying still matters, because motion artifact degrades images and can force a repeat sequence.

Turnaround on the report is typically a matter of days rather than weeks, which is where the AI pre-screening step earns its place in the workflow. The report you receive is structured by anatomy: each region imaged, what was seen, and a recommended action — no follow-up, routine follow-up at an interval, or prompt evaluation. Onboarding end to end, from booking to report in hand, usually runs one to two weeks depending on appointment availability in your metro.

What the scan covers

MRI reads soft tissue well. That defines both the value and the limits of what Ezra can tell you. Exact anatomical coverage varies by protocol and by clinic, so confirm the list for the tier you are buying, but the regions typically imaged on the full-body protocols include:

• Brain. Structural abnormalities, masses, and vascular findings including aneurysms.
• Neck and thyroid. Nodules and masses in the soft tissue of the neck.
• Chest and upper abdomen. Soft-tissue structures; note that MRI is not the standard modality for lung parenchyma, which is a real coverage gap for smokers.
• Liver, gallbladder, pancreas and spleen. Lesions, cysts and structural changes. Pancreatic imaging is one of the areas where whole-body MRI adds coverage that routine screening does not provide.
• Kidneys and adrenal glands. Masses and cysts, which are also the most common source of benign incidental findings.
• Pelvic organs. Prostate in men; uterus and ovaries in women.
• Spine. Cervical, thoracic and lumbar structures, including disc and degenerative findings.
• Major vessels. Aortic dimensions and aneurysmal dilation.

What it does not cover matters equally. MRI does not replace a colonoscopy for colorectal polyps, does not replace a mammogram for breast screening, does not read coronary calcium the way a cardiac CT does, and detects lung nodules far less reliably than low-dose CT. A clean whole-body MRI is not a clean bill of health across all cancers, and reading it that way is the most expensive mistake in this category.

Strengths

• Category track record. Ezra was the first US direct-to-consumer whole-body MRI provider, which means a longer operating history than newer entrants.
• AI-assisted workflow. Machine pre-screening focuses the radiologist's attention and shortens report turnaround, with a human signing the final read.
• A genuine low-cost entry tier. The ~$1,395 Flash lets someone test the category for a third less than the top of Prenuvo's range, with a shorter time in the bore.
• Zero ionizing radiation. MRI carries no radiation dose, so repeating it does not accumulate risk the way repeated CT screening would.
• Fixed, published pricing. Three tiers, three numbers, no membership and no recurring commitment. You can budget the purchase exactly.
• Coverage of anatomy routine screening skips. Pancreas, kidneys, and the aorta are not part of standard age-based screening for most adults, and structural findings there can be genuinely consequential.

Trade-offs

• Incidentaloma rate. Benign findings that require follow-up imaging are common with any whole-body MRI. The cost, the delay, and the anxiety of a workup that ends in nothing are real and are not priced into the scan.
• Clinical debate. Major medical societies do not currently recommend whole-body MRI screening for asymptomatic average-risk adults, and mortality-benefit evidence at population scale is not established.
• Location availability. The US clinic footprint is growing but concentrated in major metros, so travel is a real cost for many buyers.
• No treatment relationship. Ezra produces imaging and a report. It does not manage findings, prescribe, or provide ongoing care.
• Coverage gaps against standard screening. Colon, breast, lung and coronary screening each need their own modality. The scan supplements them and does not substitute for any of them.
• MRI eligibility rules exclude some buyers outright. Implanted devices, retained metal, bore-size limits and severe claustrophobia can disqualify you after you have already made the decision to buy.

How it compares

The table below lists Ezra alongside its closest peers, listed alphabetically, with the same four criteria applied to every row. Ezra and Prenuvo are the direct substitutes: both are whole-body MRI, both are single-purchase, both end at a radiologist report. Galleri sits beside them rather than against them, because a blood-based multi-cancer test finds a different class of signal than an MRI does. Fountain Life is the bundled option, where imaging is one component of a concierge membership priced an order of magnitude higher.

Read across the rows and the decision clarifies. If you want imaging and nothing else, Ezra and Prenuvo are the two candidates and clinic proximity usually decides it. If your specific worry is cancer rather than structural findings, Galleri covers cancer types MRI cannot reach, at roughly a third of the price of a full-body scan, and the two are frequently layered rather than chosen between. If you want the imaging inside a program that also runs bloodwork and assigns you a physician, Fountain Life does that at a starting price above $19,500 a year.

Who should buy it — and who should not

Buy it if:

• You have a family history of a cancer that standard age-based screening does not cover — pancreatic and renal are the common cases.
• You have a specific structural concern, such as a family history of aortic aneurysm or an unexplained persistent symptom your physician wants imaged.
• You can absorb a follow-up workup out of pocket without financial strain, because that tail is the part nobody quotes you.
• You want a lower-cost way into the category and the ~$1,395 Flash tier fits a budget that a $2,499 full-body scan does not.

Look elsewhere if:

• Your actual question is cancer risk rather than anatomy — buy Galleri instead, which screens 50+ cancer types from a blood draw at roughly $949.
• You want the imaging bundled with biomarkers and a physician who manages the results — buy a Fountain Life membership instead, and price the whole year rather than the scan.
• You are due for a colonoscopy, mammogram, or low-dose lung CT — buy those first, because they have mortality-benefit evidence a whole-body MRI does not.
• You have a pacemaker, a cochlear implant, retained metal fragments, or severe claustrophobia — no MRI provider can serve you, and blood-based screening such as Galleri is the workable alternative.

One non-obvious case sits outside both lists. If you already know you are an anxious health consumer — someone who has previously spiralled on an ambiguous result — the incidentaloma rate is not an abstraction. Roughly a third to a half of whole-body screening scans surface something the report flags for follow-up, and most of those resolve as nothing. Decide in advance how you will handle an ambiguous kidney cyst before you book, not after the report arrives.

Retesting and what year two costs

Ezra markets annual repeat scanning, and because MRI carries no radiation dose there is no cumulative-exposure argument against repeating it. The argument against annual repetition is different: for an asymptomatic adult with a clean baseline scan, the yield of the second scan is lower than the first, while the chance of surfacing a new benign finding stays roughly constant.

Pricing does not reward loyalty. There is no published membership rate or returning-customer discount, so year two costs the same as year one — roughly $1,395 at the Flash tier, roughly $1,995 for Full Body, roughly $2,395 for Full Body Plus. A buyer scanning annually at the Full Body tier is committing to about $4,000 across two years before any follow-up costs.

A defensible middle path for average-risk adults is a baseline scan, then repeat at two to three years rather than annually, with the interval shortened only if the baseline flagged something worth watching. If your baseline surfaced a lesion the radiologist recommended tracking, follow the interval in the report rather than the marketing calendar — that recommendation is anatomy-specific and typically tighter than a generic annual cadence.

Related

• Prenuvo vs Ezra — the two providers side by side
• Prenuvo review — the other whole-body MRI provider
• Galleri review — blood-based multi-cancer screening
• Fountain Life review — imaging inside a concierge program
• Doctor-led options — every physician-supervised program compared
• All platform reviews